Many cancers evade the immune response by acting on specific proteins that regulate T-cell differentiation, such as CTLA-4 (cytotoxic T lymphocyte-associated protein 4), PD-1 (programmed cell death 1), and PD-L1 (PD-1 ligand 1). The gene discussed is CTLA4; the disease is cancer.